IdentifySensors
  • Technology
  • Solutions
    • Biologics
    • Food Safety & Sustainability
    • Infrastructure & Environmental Monitoring
    • National Security
  • Press Room
  • About
  • Contact
Select Page
IDENTIFYSENSORS BIOLOGICS RECEIVES TECHOHIO START-UP AWARD

IDENTIFYSENSORS BIOLOGICS RECEIVES TECHOHIO START-UP AWARD

by Rhett Butler | Aug 17, 2021 | App, Biologics, Check4, Covid, Press

IDENTIFYSENSORS BIOLOGICS RECEIVES TECHOHIO START-UP AWARD Article Source:  August 17, 2021  App, Biologics, Check4, Covid, Press Cleveland – IdentifySensors Biologics, along with leading researchers at Purdue University, developed a breakthrough...
IdentifySensors Technology Platform uses Electronic Nanosensors to Detect Genetic Materials

IdentifySensors Technology Platform uses Electronic Nanosensors to Detect Genetic Materials

by Rhett Butler | Aug 15, 2021 | App, Biologics, Check4, Covid, Press

IdentifySensors Develops Fast, Accurate, Over-the-counter RNA Self-test Article Source: https://www.businesswire.com  August 14, 2021  App, Biologics, Check4, Covid, Press CLEVELAND--(BUSINESS WIRE)--Nanosensor technology firm IdentifySensors Biologics...
IdentifySensors Develops Fast, Accurate, Over-the-counter RNA Self-test

IdentifySensors Develops Fast, Accurate, Over-the-counter RNA Self-test

by Rhett Butler | Aug 14, 2021 | App, Biologics, Check4, Covid, Press

IdentifySensors Develops Fast, Accurate, Over-the-counter RNA Self-test Article Source: https://www.businesswire.com  August 14, 2021  App, Biologics, Check4, Covid, Press CLEVELAND--(BUSINESS WIRE)--Nanosensor technology firm IdentifySensors Biologics...
IdentifySensors Biologics Moves New Pathogen Testing Platform To Commercialization Stage

IdentifySensors Biologics Moves New Pathogen Testing Platform To Commercialization Stage

by Rhett Butler | Aug 14, 2021 | Biologics, Check4, Covid, Press

IdentifySensors Biologics Moves New Pathogen Testing Platform To Commercialization Stage Article Source: https://www.prnewswire.com  August 14, 2021  Biologics, Check4, Covid, Press Replacing 50-year-old chemical diagnostics, such as PCR and antigen...
Purdue Research Foundation partners with IdentifySensors

Purdue Research Foundation partners with IdentifySensors

by learnfrankly@gmail.com | Aug 14, 2021 | Biologics, Check4, Covid, Press

Purdue Research Foundation partners with IdentifySensors Article Source: https://www.purdue.edu  August 14, 2021  Biologics, Check4, Covid, Press IdentifySensors Biologics, a Purdue University-affiliated technology firm developing a rapid diagnostic...
Ohio doctor develops fast self-testing for COVID-19

Ohio doctor develops fast self-testing for COVID-19

by Rhett Butler | Jul 7, 2021 | Biologics, Check4, Covid, Press

Ohio doctor develops fast self-testing for COVID-19 Article Source: https://spectrumnews1.com  July 7, 2021  Biologics, Check4, Covid, Press Ohio State Medical School graduate, trauma surgeon and entrepreneur Dr. Gregory Hummer was enjoying retirement...

Categories

  • App
  • Biologics
  • Check4
  • Covid
  • Press

Tags

Biologics Check4 Covid Self-Test Technology

Press & Highlights

IDENTIFYSENSORS BIOLOGICS RECEIVES TECHOHIO START-UP AWARD

Aug 17, 2021

Learn More

IdentifySensors Technology Platform uses Electronic Nanosensors to Detect Genetic Materials

Aug 15, 2021

Learn More

IdentifySensors Develops Fast, Accurate, Over-the-counter RNA Self-test

Aug 14, 2021

Learn More

IdentifySensors Biologics Moves New Pathogen Testing Platform To Commercialization Stage

Aug 14, 2021

Learn More

Purdue Research Foundation partners with IdentifySensors

Aug 14, 2021

Learn More

Ohio doctor develops fast self-testing for COVID-19

Jul 7, 2021

Learn More

Check4-COVID by IdentifySensors Biologics Allows For Accurate Results Within Minutes On Your Phone

Jan 11, 2021

Learn More

Bloomberg Business – IdentifySensors Biologics Develops Fast, Accurate, Over-the-counter RNA COVID Self-test

Dec 28, 2020

Learn More

Cleveland based IdentifySensors developing rapid, at-home COVID-19 test

Dec 3, 2020

Learn More

New Electronic Biological Diagnostics Test

Nov 15, 2020

Learn More

Aiming For Faster Coronavirus Test Results

Nov 7, 2020

Learn More
Press Room

MEDIA & PRESS INQUIRES

Communications: Joe Mosbrook
(216) 375-2141
mosbrook@acclaimllc.com

Find out more about our Patents & Technologies

Request
Information

15 + 4 =

identifysensors company logo

SOLUTIONS

Biologics

Food Safety

Infrastructure & Environment

National Security

COMPANY

ABOUT US

Leadership

CONTACT

Privacy

FACEBOOK
LINKEDIN
YOUTUBE

DISCLAIMER:

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

THE COMPANY IS RAISING CAPITAL FOR EXPANSION VIA an offering exempt from registration under Regulation A. FOR DETAILS, VISIT THE COMPANY’S INVESTMENT PAGE.

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. Offers and sales of our securities are made only by the offering circular. YOU MAY OBTAIN A COPY OF THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT FROM: ISB-Updated-offering-circular-03.10.2021.pdf

YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

©2021 IDENTIFYSENSORS, LLC, ALL RIGHTS RESERVED.